Benzinga | Nov 5, 2020 04:56PM EST

Theravance Biopharma Q3 EPS $(1.16) Misses $(0.97) Estimate, Sales $18.30M Miss $18.58M Estimate

Theravance Biopharma (NASDAQ:TBPH) reported quarterly losses of $(1.16) per share which missed the analyst consensus estimate of $(0.97) by 19.59 percent. This is a 10.48 percent decrease over losses of $(1.05) per share from the same period last year. The company reported quarterly sales of $18.30 million which missed the analyst consensus estimate of $18.58 million by 1.51 percent. This is a 47.26 percent increase over sales of $12.43 million the same period last year.